People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

HIV is a virus that attacks cells in the body fighting off infections ... Through their analysis, they predicted and ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

If you do this, it'll help you: Strengthen your immune system Lessen the chances of infection of any type Lessen your chances of getting "treatment-resistant" HIV Lessen your chances of passing ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

SAN FRANCISCO — Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, baseline suppressive therapies among adults with HIV.

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...